Cedric Francois

Chief Executive Officer at Apellis Pharmaceuticals · 13 reported transactions in 1 company · latest trade Jan 22, 2026

Their trades


Apellis PharmaceuticalsAPLS	Sold $591.8K · 27,192 shares	Jan 22, 2026
Apellis PharmaceuticalsAPLS	Sold $161.9K · 8,182 shares	Jan 20, 2026
Apellis PharmaceuticalsAPLS	Sold $226K · 10,186 shares	Jan 13, 2026
Apellis PharmaceuticalsAPLS	Sold $1.42M · 49,963 shares	Aug 28, 2025
Apellis PharmaceuticalsAPLS	Sold $4.93M · 175,037 shares	Aug 27, 2025
Apellis PharmaceuticalsAPLS	Sold $398.7K · 19,725 shares	Jul 17, 2025
Apellis PharmaceuticalsAPLS	Sold $38.2K · 1,900 shares	Jul 15, 2025

Jan 22, 2026 · APLS

$591.8K

Jan 20, 2026 · APLS

$161.9K

Jan 13, 2026 · APLS

$226K

Aug 28, 2025 · APLS

$1.42M

Aug 27, 2025 · APLS

$4.93M

Jul 17, 2025 · APLS

$398.7K

Jul 15, 2025 · APLS

$38.2K

Newest 10 of 13 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Executive Officer at Apellis Pharmaceuticals · 13 reported transactions in 1 company · latest trade Jan 22, 2026


Apellis PharmaceuticalsAPLS	Sold $591.8K · 27,192 shares	Jan 22, 2026
Apellis PharmaceuticalsAPLS	Sold $161.9K · 8,182 shares	Jan 20, 2026
Apellis PharmaceuticalsAPLS	Sold $226K · 10,186 shares	Jan 13, 2026
Apellis PharmaceuticalsAPLS	Sold $1.42M · 49,963 shares	Aug 28, 2025
Apellis PharmaceuticalsAPLS	Sold $4.93M · 175,037 shares	Aug 27, 2025
Apellis PharmaceuticalsAPLS	Sold $398.7K · 19,725 shares	Jul 17, 2025
Apellis PharmaceuticalsAPLS	Sold $38.2K · 1,900 shares	Jul 15, 2025